Global B2B Pharmaceutical Sourcing · Dossier Licensing · Named-Patient Access
💬 WhatsApp · Sign in · Register

Transdermal Patch Contract Manufacturing

Medicated skin patches made under your brand by specialist manufacturers, for prescription, OTC and pain-relief products.

Few plants make patches, and adhesion is the hard part

A transdermal patch delivers a drug through the skin over hours or days. Most modern patches are matrix patches, where the drug is mixed into the adhesive layer. Older reservoir patches hold the drug in a separate compartment behind a membrane.

Only a small number of manufacturers worldwide make them, including a handful in India. The technology is in the coating and laminating line and in the testing: the patch has to stick for the full wear time, release the right dose, and not leave the drug behind or ooze at the edges.

We shortlist patch makers by product type and by the approvals your market needs, and we share their data before you commit.

Tell us this to get a quote

  • Molecule and dose (for example mg per 24 hours) and wear time
  • Matrix or reservoir, patch size
  • Prescription, OTC or medicated plaster for pain relief
  • Target market(s)
  • Pack: individual sachets, pack size
  • Annual volume
  • Your own formula and dossier, or the manufacturer's

What to check in a patch manufacturer

Approvals for your market

WHO-GMP and a CoPP for emerging markets. For the EU, UK or US, the site must be inspected by that regulator, and the dossier must include the adhesion and irritation data those regulators expect.

Adhesion data

Peel, tack and shear tests in the lab, and for regulated markets a study of adhesion on people over the full wear time. Patches that lift early under-dose.

Release and residual drug

In-vitro release testing, and the amount of drug left in a used patch. A high residual amount is a safety and disposal issue for some molecules.

Cold flow and stability

Adhesive can creep past the patch edge in storage. Ask for stability data covering cold flow, crystal formation and release at the end of shelf life.

Controlled molecules

Some patch molecules are controlled substances, which need extra licences and are handled case by case. We do not take them through general enquiries.

Capacity

Coating and laminating lines run in campaigns. Ask about minimum run per strength and the lead time for each campaign.

Matrix or reservoir?

Matrix (drug-in-adhesive)Reservoir
How it worksDrug mixed into the adhesive layerDrug held in a compartment, released through a rate-controlling membrane
Thickness and comfortThin, flexibleThicker
Risk if damagedLower; cutting is still not advised unless labelledHigher; a damaged membrane can release too much drug
Typical examplesNicotine, estradiol, rivastigmine, rotigotine, nitroglycerin, lidocaineSome older nitroglycerin and scopolamine patches

Most new patch products and generics are matrix designs. Pain-relief plasters with diclofenac or menthol are a separate, simpler category.

How it works with PharmaTradz

1
Brief

You send the molecule, dose, wear time, market and volume.

2
Shortlist with data

Patch makers that already make that type, with approvals, adhesion and release data, and country of manufacture. Names under a confidential disclosure agreement when the requirement is firm.

3
Samples and formula

Samples of an existing product, or development, adhesion and stability work for a new one.

4
Artwork and registration

Your brand, sachet and carton artwork, and the dossier for your market.

5
Commercial batches

Production and release with a batch-wise CoA, including adhesion and release tests.

6
Repeat supply

Scheduled campaigns against your forecast.

Problems we see most often

Patches that fall off

Usually an adhesive that is too weak for heat, sweat or the body site. Ask for adhesion data from conditions like your market's climate.

Crystals in the patch

The drug comes out of solution in the adhesive during storage, and release drops. Ask what stability shows at the end of shelf life.

Sticky edges in the sachet

Cold flow of adhesive past the edge, often from storage that is too warm. Check the release liner and sachet specification.

Looking for a transdermal patch manufacturer?

Send the molecule, dose, wear time, market and annual volume. We will tell you plainly which manufacturers fit and what data they hold.

Send your requirement Talk to our team

Frequently Asked Questions

A medicated patch that sticks to the skin and delivers a drug into the bloodstream over a set time, often 24 hours to 7 days. It gives steady drug levels and avoids the stomach and first-pass metabolism.

A small number of specialist companies worldwide, including a few in India, because patches need dedicated coating and laminating lines and specialised testing. We shortlist manufacturers by patch type, molecule and approvals.

In a matrix patch the drug is mixed into the adhesive. In a reservoir patch it sits in a separate compartment behind a membrane. Most new products use matrix designs because they are thinner and safer if damaged.

Assay and content uniformity, in-vitro release, adhesion (peel, tack and shear), residual drug, cold flow and stability. Regulated markets also expect studies of adhesion and skin irritation on people.

Yes, where the manufacturer licenses or supplies the product for your market. Your brand appears as the marketer and the manufacturer is named too.

Not through general enquiries. Controlled molecules need import and export licences in both countries and are considered case by case only.

Subscribe to Our Newsletter

Stay updated on pharma trends and sourcing opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.
WhatsApp us